|
1
|
Sheikh MA, Malik YS, Yu H, Lai M, Wang X
and Zhu X: Epigenetic regulation of Dpp6 expression by Dnmt3b and
its novel role in the inhibition of RA induced neuronal
differentiation of P19 cells. PLoS One. 8:e558262013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Succony L, Rassl DM, Barker AP, McCaughan
FM and Rintoul RC: Adenocarcinoma spectrum lesions of the lung:
Detection, pathology and treatment strategies. Cancer Treat Rev.
99:1022372021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bade BC and Dela Cruz CS: Lung cancer
2020: Epidemiology, etiology, and prevention. Clin Chest Med.
41:1–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zito Marino F, Bianco R, Accardo M, Ronchi
A, Cozzolino I, Morgillo F, Rossi G and Franco R: Molecular
heterogeneity in lung cancer: From mechanisms of origin to clinical
implications. Int J Med Sci. 16:981–989. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kan Z, Jaiswal BS, Stinson J, Janakiraman
V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, et al:
Diverse somatic mutation patterns and pathway alterations in human
cancers. Nature. 466:869–873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wheeler DA and Wang L: From human genome
to cancer genome: the first decade. Genome Res. 23:1054–1062. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jha G, Azhar S, Rashid U, Khalaf H,
Alhalabi N, Ravindran D and Ahmad R: Epigenetics: The key to future
diagnostics and therapeutics of lung cancer. Cureus.
13:e197702021.PubMed/NCBI
|
|
8
|
Rauch TA, Wang Z, Wu X, Kernstine KH,
Riggs AD and Pfeifer GP: DNA methylation biomarkers for lung
cancer. Tumour Biol. 33:287–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chao YL and Pecot CV: Targeting
epigenetics in lung cancer. Cold Spring Harb Perspect Med.
11:a0380002021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Selamat SA, Galler JS, Joshi AD, Fyfe MN,
Campan M, Siegmund KD, Kerr KM and Laird-Offringa IA: DNA
methylation changes in atypical adenomatous hyperplasia,
adenocarcinoma in situ, and lung adenocarcinoma. PLoS One.
6:e214432011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung JH, Lee HJ, Kim BH, Cho NY and Kang
GH: DNA methylation profile during multistage progression of
pulmonary adenocarcinomas. Virchows Arch. 459:201–211. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kajiura K, Masuda K, Naruto T, Kohmoto T,
Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A and Imoto I:
Frequent silencing of the candidate tumor suppressor TRIM58 by
promoter methylation in early-stage lung adenocarcinoma.
Oncotarget. 8:2890–2905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Strop P, Bankovich AJ, Hansen KC, Garcia
KC and Brunger AT: Structure of a human A-type potassium channel
interacting protein DPPX, a member of the dipeptidyl aminopeptidase
family. J Mol Biol. 343:1055–1065. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nadal MS, Ozaita A, Amarillo Y, Vega-Saenz
de Miera E, Ma Y, Mo W, Goldberg EM, Misumi Y, Ikehara Y, Neubert
TA and Rudy B: The CD26-related dipeptidyl aminopeptidase-like
protein DPPX is a critical component of neuronal A-type K+
channels. Neuron. 37:449–461. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao X, Cao D, Ren Z, Liu Z, Lv S, Zhu J,
Li L, Lang R and He Q: Dipeptidyl peptidase like 6 promoter
methylation is a potential prognostic biomarker for pancreatic
ductal adenocarcinoma. Biosci Rep. 40:BSR202002142020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xi T and Zhang G: Epigenetic regulation on
the gene expression signature in esophagus adenocarcinoma. Pathol
Res Pract. 213:83–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saied MH, Marzec J, Khalid S, Smith P,
Down TA, Rakyan VK, Molloy G, Raghavan M, Debernardi S and Young
BD: Genome wide analysis of acute myeloid leukemia reveal leukemia
specific methylome and subtype specific hypomethylation of repeats.
PLoS One. 7:e332132012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang HW, Park H, Seo SP, Byun YJ, Piao XM,
Kim SM, Kim WT, Yun SJ, Jang W, Shon HS, et al: Methylation
signature for prediction of progression free survival in surgically
treated clear cell renal cell carcinoma. J Korean Med Sci.
34:e1442019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li M, Zhang C, Zhou L, Li S, Cao YJ, Wang
L, Xiang R, Shi Y and Piao Y: Identification and validation of
novel DNA methylation markers for early diagnosis of lung
adenocarcinoma. Mol Oncol. 14:2744–2758. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions, .
The IASLC lung cancer staging project: proposals for the revision
of the TNM stage groupings in the forthcoming (seventh) edition of
the TNM Classification of malignant tumours. J Thorac Oncol.
2:706–714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: Introduction to the 2015 world health
organization classification of tumors of the lung, pleura, thymus,
and heart. J Thorac Oncol. 10:1240–1242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sedo A and Kraml J: Dipeptidyl peptidase
IV in cell proliferation and differentiation. Sb Lek. 95:285–288.
1994.PubMed/NCBI
|
|
23
|
Kotacková L, Baláziová E and Sedo A:
Expression pattern of dipeptidyl peptidase IV activity and/or
structure homologues in cancer. Folia Biol (Praha). 55:77–84.
2009.PubMed/NCBI
|
|
24
|
Jones S, Zhang X, Parsons DW, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et
al: Core signaling pathways in human pancreatic cancers revealed by
global genomic analyses. Science. 321:1801–1806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choy TK, Wang CY, Phan NN, Khoa Ta HD,
Anuraga G, Liu YH, Wu YF, Lee KH, Chuang JY and Kao TJ:
Identification of Dipeptidyl Peptidase (DPP) family genes in
clinical breast cancer patients via an integrated bioinformatics
approach. Diagnostics (Basel). 11:12042021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jia Y, Shen M, Zhou Y and Liu H:
Development of a 12-biomarkers-based prognostic model for
pancreatic cancer using multi-omics integrated analysis. Acta
Biochim Pol. 67:501–508. 2020.PubMed/NCBI
|
|
27
|
Kolat D, Kaluzinska Z, Bednarek AK and
Pluciennik E: Prognostic significance of AP-2α/γ targets as cancer
therapeutics. Sci Rep. 12:54972022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Xu Y, Li Z, Zhu Y, Wen S, Wang M,
Lv H, Zhang F and Tian Z: Identification of the key transcription
factors in esophageal squamous cell carcinoma. J Thorac Dis.
10:148–161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z,
Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al:
The human colon cancer methylome shows similar hypo- and
hypermethylation at conserved tissue-specific CpG island shores.
Nat Genet. 41:178–186. 2009. View
Article : Google Scholar : PubMed/NCBI
|
